Skip to main navigation Skip to search Skip to main content

Current status of conversion therapy after multidisciplinary treatment in initially unresectable advanced esophageal cancer: a narrative review

Research output: Contribution to journal › Review article › peer-review

Abstract

Background and Objective: Conversion therapy (CT) for initially unresectable esophageal cancer (EC) has emerged as a potential curative strategy. However, clinical evidence remains heterogeneous. This narrative review aimed to evaluate the current evidence, surgical indications, and clinical outcomes of CT, including conversion surgery (CS), in the era of potent systemic therapies. Methods: A literature search was conducted in PubMed for English-language literature prior to December 2025 to identify relevant original articles, clinical trials, and retrospective studies. We focused on the key evidence regarding induction chemotherapy, chemoradiotherapy, and recent immunotherapy in the context of CS. Key Content and Findings: For cT4b disease, definitive chemoradiotherapy or induction chemotherapy using intensive multi-drug regimens [e.g. docetaxel + cisplatin + 5-fluorouracil (DCF)] shows promising R0 resection rates. In cM1 disease, particularly with distant lymph node metastasis, CS may offer long-term survival for exceptional responders, although significant selection bias exists. The integration of immunochemotherapy (CheckMate 648, KEYNOTE-590, RATIONALE-306) has significantly improved systemic control, but its specific impact on surgical morbidity and long-term outcomes in CT requires further validation. Conclusions: Evidence for CT in initially unresectable EC is increasing, and R0 resection can yield favorable outcomes. However, it remains unclear whether CT is superior to continuing initial treatments. Further studies are warranted to establish the definitive role of CT.

Original languageEnglish
Article number13
JournalAnnals of Esophagus
Volume9
DOIs
Publication statusPublished - 2026 Jun 30

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • conversion surgery (CS)
  • conversion therapy (CT)
  • Esophagectomy
  • immunochemotherapy
  • immunotherapy

ASJC Scopus subject areas

  • Surgery
  • Gastroenterology

Fingerprint

Dive into the research topics of 'Current status of conversion therapy after multidisciplinary treatment in initially unresectable advanced esophageal cancer: a narrative review'. Together they form a unique fingerprint.

Cite this